Position in AKBA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$939,161
+$502,365 QoQ
Shares Held
675,656
+149.0% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Voleon Capital Management LP holds $33,931,226 across 13 Drug Manufacturers - Specialty & Generic names. AKBA ranks #9 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRX |
Amneal Pharmaceuticals, Inc.
|
786,764 | $9,779,476 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
120,385 | $5,796,537 | |
| 3 | ZTS |
Zoetis Inc.
|
34,035 | $4,023,277 | |
| 4 | VTRS |
Viatris Inc
|
281,157 | $3,798,431 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
164,921 | $3,423,759 | |
| 6 | ADCT |
ADC Therapeutics SA
|
513,831 | $1,926,866 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
3,105 | $1,841,202 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
7,638 | $1,006,230 |
All Filings in AKBA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $939,161 | 675,656 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $436,796 | 271,302 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $578,121 | 211,766 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||